Infectious Disease Alert – February 1, 2019
February 1, 2019
View Issues
-
Treatment of Gram-Negative Bacteremia: How Long Is Long Enough?
Antibiotic administration for seven days is sufficient in stable patients with Gram-negative bacteremia.
-
A Nosocomial Outbreak at the NIH Clinical Center From Sphingomonas koreensis, a Rare Human Pathogen
A genomic and epidemiologic investigation of an outbreak at the National Institutes of Health Clinical Center determined that S. koreensis was an opportunistic human pathogen that persisted in a reservoir in the hospital plumbing.
-
Duration of Intravenous Antibiotic Therapy for Late-Onset Neonatal Group B Streptococcal Bacteremia
Although standard treatment of late-onset neonatal group B Streptococcus bacteremia includes intravenous antibiotic therapy for 10 days, shorter courses seem safe and effective.
-
Rotavirus Vaccine and Hospitalization for Seizures
In an analysis of insurance claims for 1.8 million U.S. children with 2,950 recorded seizures, researchers found that the risk of hospitalization for seizures was 24% lower in rotavirus-vaccinated children.
-
A Rabies Death in Virginia
A Virginia resident who had not received pre- or post-exposure prophylaxis died of rabies resulting from a dog bite during a prolonged trip to India. Many exposed healthcare workers subsequently received post-exposure prophylaxis.
-
Rifamycin Delayed-Release Tablets (Aemcolo)
-
Playing Opossum: A New Model of Antibiotic and Immune Resistance
Researchers observed nongrowing cells of Salmonella that remained persistent, resisted antibiotics, and retained infectivity.
-
Infectious Disease Alert Updates
The Great Leveler; Increased Cancer Risk in HIV (Even With Long-Term Suppression)